• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,432.07 -896.12
( -1.16%)
Global Indices
Nasdaq
49,619.91 1.93
(0.00%)
Dow Jones
7,417.79 59.68
(0.81%)
Hang Seng
62,681.30 -152.54
(-0.24%)
Nikkei 225
10,228.01 -48.94
(-0.48%)
Forex
USD-INR
94.38 -0.30
(-0.31%)
EUR-INR
110.93 -0.26
(-0.23%)
GBP-INR
128.32 -0.39
(-0.30%)
JPY-INR
0.60 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Gennex Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
531739
INE509C01026
8.6694335
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
16.13
242.95
EPS(TTM)
Face Value()
Div & Yield %
0.62
1
0
 

Lloyds Enterprises consolidated net profit rises 304.14% in the March 2026 quarter
May 08,2026
Net profit of Lloyds Enterprises rose 304.14% to Rs 38.11 crore in the quarter ended March 2026 as against Rs 9.43 crore during the previous quarter ended March 2025. Sales rose 47.07% to Rs 719.64 crore in the quarter ended March 2026 as against Rs 489.32 crore during the previous quarter ended March 2025.

For the full year,net profit rose 396.39% to Rs 283.44 crore in the year ended March 2026 as against Rs 57.10 crore during the previous year ended March 2025. Sales rose 18.01% to Rs 1756.29 crore in the year ended March 2026 as against Rs 1488.29 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales719.64489.32 47 1756.291488.29 18
OPM %6.295.07 -6.607.93 -
PBDT98.6945.11 119 495.44173.83 185
PBT91.6641.86 119 472.61163.15 190
NP38.119.43 304 283.4457.10 396